Cargando…
Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466]
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198372/ https://www.ncbi.nlm.nih.gov/pubmed/35696745 http://dx.doi.org/10.1016/j.esmoop.2022.100523 |
_version_ | 1784727599916777472 |
---|---|
author | Sinn, K. Mosleh, B. Steindl, A. Zoechbauer-Mueller, S. Dieckmann, K. Widder, J. Steiner, E. Klepetko, W. Hoetzenecker, K. Laszlo, V. Dome, B. Klikovits, T. Hoda, M.A. |
author_facet | Sinn, K. Mosleh, B. Steindl, A. Zoechbauer-Mueller, S. Dieckmann, K. Widder, J. Steiner, E. Klepetko, W. Hoetzenecker, K. Laszlo, V. Dome, B. Klikovits, T. Hoda, M.A. |
author_sort | Sinn, K. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9198372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-91983722022-06-16 Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466] Sinn, K. Mosleh, B. Steindl, A. Zoechbauer-Mueller, S. Dieckmann, K. Widder, J. Steiner, E. Klepetko, W. Hoetzenecker, K. Laszlo, V. Dome, B. Klikovits, T. Hoda, M.A. ESMO Open Corrigendum Elsevier 2022-06-10 /pmc/articles/PMC9198372/ /pubmed/35696745 http://dx.doi.org/10.1016/j.esmoop.2022.100523 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Corrigendum Sinn, K. Mosleh, B. Steindl, A. Zoechbauer-Mueller, S. Dieckmann, K. Widder, J. Steiner, E. Klepetko, W. Hoetzenecker, K. Laszlo, V. Dome, B. Klikovits, T. Hoda, M.A. Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466] |
title | Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466] |
title_full | Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466] |
title_fullStr | Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466] |
title_full_unstemmed | Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466] |
title_short | Corrigendum to ‘Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study’: [ESMO Open Volume 7, Issue 2, April 2022, 100466] |
title_sort | corrigendum to ‘neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage iii/n2 non-small-cell lung cancer: a retrospective single-center cohort study’: [esmo open volume 7, issue 2, april 2022, 100466] |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198372/ https://www.ncbi.nlm.nih.gov/pubmed/35696745 http://dx.doi.org/10.1016/j.esmoop.2022.100523 |
work_keys_str_mv | AT sinnk corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466 AT moslehb corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466 AT steindla corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466 AT zoechbauermuellers corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466 AT dieckmannk corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466 AT widderj corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466 AT steinere corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466 AT klepetkow corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466 AT hoetzeneckerk corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466 AT laszlov corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466 AT domeb corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466 AT klikovitst corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466 AT hodama corrigendumtoneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudyesmoopenvolume7issue2april2022100466 |